These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 38753093)
1. Long term follow-up of patients with newly diagnosed glioblastoma treated by intraoperative photodynamic therapy: an update from the INDYGO trial (NCT03048240). Peciu-Florianu I; Vannod-Michel Q; Vauleon E; Bonneterre ME; Reyns N J Neurooncol; 2024 Jul; 168(3):495-505. PubMed ID: 38753093 [TBL] [Abstract][Full Text] [Related]
2. Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial. Vermandel M; Dupont C; Lecomte F; Leroy HA; Tuleasca C; Mordon S; Hadjipanayis CG; Reyns N J Neurooncol; 2021 May; 152(3):501-514. PubMed ID: 33743128 [TBL] [Abstract][Full Text] [Related]
3. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study. da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282 [TBL] [Abstract][Full Text] [Related]
4. INtraoperative photoDYnamic Therapy for GliOblastomas (INDYGO): Study Protocol for a Phase I Clinical Trial. Dupont C; Vermandel M; Leroy HA; Quidet M; Lecomte F; Delhem N; Mordon S; Reyns N Neurosurgery; 2019 Jun; 84(6):E414-E419. PubMed ID: 30053213 [TBL] [Abstract][Full Text] [Related]
5. Interstitial 5-ALA photodynamic therapy and glioblastoma: Preclinical model development and preliminary results. Tetard MC; Vermandel M; Leroy HA; Leroux B; Maurage CA; Lejeune JP; Mordon S; Reyns N Photodiagnosis Photodyn Ther; 2016 Mar; 13():218-224. PubMed ID: 26213327 [TBL] [Abstract][Full Text] [Related]
6. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles. Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389 [TBL] [Abstract][Full Text] [Related]
7. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial. de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973 [TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB; Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399 [TBL] [Abstract][Full Text] [Related]
9. The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. A two-center, prospective assessor-blinded, proof-of-concept study. Serini SM; Cannizzaro MV; Dattola A; Garofalo V; Del Duca E; Ventura A; Milani M; Campione E; Bianchi L J Cosmet Dermatol; 2019 Feb; 18(1):156-162. PubMed ID: 29790262 [TBL] [Abstract][Full Text] [Related]
10. Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors. Muragaki Y; Akimoto J; Maruyama T; Iseki H; Ikuta S; Nitta M; Maebayashi K; Saito T; Okada Y; Kaneko S; Matsumura A; Kuroiwa T; Karasawa K; Nakazato Y; Kayama T J Neurosurg; 2013 Oct; 119(4):845-52. PubMed ID: 23952800 [TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345 [TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy in the treatment of brain tumours. A feasibility study. Vanaclocha V; Sureda M; Azinovic I; Rebollo J; Cañón R; Sapena NS; Cases FG; Brugarolas A Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):422-7. PubMed ID: 26073912 [TBL] [Abstract][Full Text] [Related]
13. Outcome of patients affected by newly diagnosed glioblastoma undergoing surgery assisted by 5-aminolevulinic acid guided resection followed by BCNU wafers implantation: a 3-year follow-up. Della Puppa A; Lombardi G; Rossetto M; Rustemi O; Berti F; Cecchin D; Gardiman MP; Rolma G; Persano L; Zagonel V; Scienza R J Neurooncol; 2017 Jan; 131(2):331-340. PubMed ID: 27757721 [TBL] [Abstract][Full Text] [Related]
14. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme. Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509 [TBL] [Abstract][Full Text] [Related]
15. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Pech O; Gossner L; May A; Rabenstein T; Vieth M; Stolte M; Berres M; Ell C Gastrointest Endosc; 2005 Jul; 62(1):24-30. PubMed ID: 15990815 [TBL] [Abstract][Full Text] [Related]
16. Comparative study of topical 5-aminolevulinic acid photodynamic therapy (5-ALA-PDT) and surgery for the treatment of high-grade vaginal intraepithelial neoplasia. Zhang Y; Su Y; Tang Y; Qin L; Shen Y; Wang B; Zhou M; Zhou Y; Cao L; Zhang T; Zhang M Photodiagnosis Photodyn Ther; 2022 Sep; 39():102958. PubMed ID: 35718105 [TBL] [Abstract][Full Text] [Related]
17. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up. Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914 [TBL] [Abstract][Full Text] [Related]
18. A pilot study of hypofractionated radiation therapy with temozolomide for adults with glioblastoma multiforme. Terasaki M; Eto T; Nakashima S; Okada Y; Ogo E; Sugita Y; Tokutomi T; Shigemori M J Neurooncol; 2011 Apr; 102(2):247-53. PubMed ID: 20640480 [TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data. Szeimies RM; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Hauschild A Br J Dermatol; 2010 Feb; 162(2):410-4. PubMed ID: 19804593 [TBL] [Abstract][Full Text] [Related]
20. Relationship between tumor cell infiltration and 5-aminolevulinic acid fluorescence signals after resection of MR-enhancing lesions and its prognostic significance in glioblastoma. Kim J-; Jung T-; Jung S; Kim I-; Jang W-; Moon K-; Kim S-; Kim J-; Lee K- Clin Transl Oncol; 2021 Mar; 23(3):459-467. PubMed ID: 32617871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]